Auger C, Alhasawi A, Contavadoo M, Appanna VD. Dysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disorders. Front Cell Dev Biol. 2015;3:40. https://doi.org/10.3389/fcell.2015.00040.

Article  PubMed  PubMed Central  Google Scholar 

Wei Y, Rector RS, Thyfault JP, Ibdah JA. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol. 2008;14:193–9. https://doi.org/10.3748/wjg.14.193.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Auger C, Sivayoganathan T, Abdullahi A, Parousis A, Jeschke MG. Hepatic mitochondrial bioenergetics in aged C57BL/6 mice exhibit delayed recovery from severe burn injury. Biochim Biophys Acta Mol Basis Dis. 2017;1863:2705–14. https://doi.org/10.1016/j.bbadis.2017.07.006.

CAS  Article  PubMed  Google Scholar 

Degli Esposti D, Hamelin J, Bosselut N, Saffroy R, Sebagh M, Pommier A, Martel C, Lemoine A. Mitochondrial roles and cytoprotection in chronic liver injury. Biochem Res Int. 2012;2012: 387626. https://doi.org/10.1155/2012/387626.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337:1062–5. https://doi.org/10.1126/science.1219855.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Simoes ICM, Fontes A, Pinton P, Zischka H, Wieckowski MR. Mitochondria in non-alcoholic fatty liver disease. Int J Biochem Cell Biol. 2018;95:93–9. https://doi.org/10.1016/j.biocel.2017.12.019.

CAS  Article  PubMed  Google Scholar 

Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679–89. https://doi.org/10.1002/hep.23280.

CAS  Article  PubMed  Google Scholar 

Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM, Leibel RL. Obesity pathogenesis: an endocrine society scientific statement. Endocr Rev. 2017;38:267–96. https://doi.org/10.1210/er.2017-00111.

Article  PubMed  PubMed Central  Google Scholar 

Pessayre D, Fromenty B. NASH: a mitochondrial disease. J Hepatol. 2005;42:928–40. https://doi.org/10.1016/j.jhep.2005.03.004.

CAS  Article  PubMed  Google Scholar 

Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17:510–9. https://doi.org/10.1111/obr.12407.

CAS  Article  PubMed  Google Scholar 

Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82–97. https://doi.org/10.1016/j.metabol.2018.11.014.

CAS  Article  PubMed  Google Scholar 

Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417:1–13. https://doi.org/10.1042/BJ20081386.

CAS  Article  PubMed  Google Scholar 

Weinberg SE, Chandel NS. Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol. 2015;11:9–15. https://doi.org/10.1038/nchembio.1712.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Aon MA, Stanley BA, Sivakumaran V, Kembro JM, O’Rourke B, Paolocci N, Cortassa S. Glutathione/thioredoxin systems modulate mitochondrial H2O2 emission: an experimental-computational study. J Gen Physiol. 2012;139:479–91. https://doi.org/10.1085/jgp.201210772.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Westermann B. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol. 2010;11:872–84. https://doi.org/10.1038/nrm3013.

CAS  Article  PubMed  Google Scholar 

Galloway CA, Yoon Y. Mitochondrial morphology in metabolic diseases. Antioxid Redox Signal. 2013;19:415–30. https://doi.org/10.1089/ars.2012.4779.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Seitz S, Kwon Y, Hartleben G, Jülg J, Sekar R, Krahmer N, Najafi B, Loft A, Gancheva S, Stemmer K, Feuchtinger A, Hrabe de Angelis M, Müller TD, Mann M, Blüher M, Roden M, Berriel Diaz M, Behrends C, Gilleron J, Herzig S, Zeigerer A. Hepatic Rab24 controls blood glucose homeostasis via improving mitochondrial plasticity. Nat Metab. 2019;1:1009–26. https://doi.org/10.1038/s42255-019-0124-x.

CAS  Article  PubMed  Google Scholar 

Wai T, Langer T. Mitochondrial dynamics and metabolic regulation. Trends Endocrinol Metab. 2016;27:105–17. https://doi.org/10.1016/j.tem.2015.12.001.

CAS  Article  PubMed  Google Scholar 

Liesa M, Shirihai OS. Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab. 2013;17:491–506. https://doi.org/10.1016/j.cmet.2013.03.002.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Zhang L, Zhang Y, Chang X, Zhang X. Imbalance in mitochondrial dynamics induced by low PGC-1alpha expression contributes to hepatocyte EMT and liver fibrosis. Cell Death Dis. 2020;11:226. https://doi.org/10.1038/s41419-020-2429-9.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Krishnasamy Y, Gooz M, Li L, Lemasters JJ, Zhong Z. Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice. International journal of physiology, pathophysiology and pharmacology. 2019;11:190–204.

CAS  PubMed  PubMed Central  Google Scholar 

Wang L, Liu X, Nie J, Zhang J, Kimball SR, Zhang H, Zhang WJ, Jefferson LS, Cheng Z, Ji Q, Shi Y. ALCAT1 controls mitochondrial etiology of fatty liver diseases, linking defective mitophagy to steatosis. Hepatology. 2015;61:486–96. https://doi.org/10.1002/hep.27420.

CAS  Article  PubMed  Google Scholar 

Pang L, Liu K, Liu D, Lv F, Zang Y, Xie F, Yin J, Shi Y, Wang Y, Chen D. Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease. Cell Death Dis. 2018;9:90. https://doi.org/10.1038/s41419-017-0136-y.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Zhang NP, Liu XJ, Xie L, Shen XZ, Wu J. Impaired mitophagy triggers NLRP3 inflammasome activation during the progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis. Lab Invest. 2019;99:749–63. https://doi.org/10.1038/s41374-018-0177-6.

CAS  Article  PubMed  Google Scholar 

Valkovic L, Chmelik M, Krssak M. In-vivo(31)P-MRS of skeletal muscle and liver: a way for non-invasive assessment of their metabolism. Anal Biochem. 2017;529:193–215. https://doi.org/10.1016/j.ab.2017.01.018.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Schmid AI, Szendroedi J, Chmelik M, Krssak M, Moser E, Roden M. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care. 2011;34:448–53. https://doi.org/10.2337/dc10-1076.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300:1140–2. https://doi.org/10.1126/science.1082889.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Oberhaensli RD, Galloway GJ, Taylor DJ, Bore PJ, Radda GK. Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy. Br J Radiol. 1986;59:695–9. https://doi.org/10.1259/0007-1285-59-703-695.

CAS  Article  PubMed  Google Scholar 

Nair S, V PC, Arnold C and Diehl AM,. Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am J Gastroenterol. 2003;98:466–70. https://doi.org/10.1111/j.1572-0241.2003.07221.x.

CAS  Article  PubMed  Google Scholar 

Bawden SJ, Stephenson MC, Ciampi E, Hunter K, Marciani L, Macdonald IA, Aithal GP, Morris PG, Gowland PA. Investigating the effects of an oral fructose challenge on hepatic ATP reserves in healthy volunteers: a (31)P MRS study. Clin Nutr. 2016;35:645–9. https://doi.org/10.1016/j.clnu.2015.04.001.

CAS  Article  PubMed  Google Scholar 

Adjeitey CN, Mailloux RJ, Dekemp RA, Harper ME. Mitochondrial uncoupling in skeletal muscle by UCP1 augments energy expenditure and glutathione content while mitigating ROS production. Am J Physiol Endocrinol Metab. 2013;305:E405–15. https://doi.org/10.1152/ajpendo.00057.2013.

CAS  Article  PubMed  PubMed Central  Google Scholar 

El-Hafidi M, Franco M, Ramirez AR, Sosa JS, Flores JAP, Acosta OL, Salgado MC, Cardoso-Saldana G. Glycine increases insulin sensitivity and glutathione biosynthesis and protects against oxidative stress in a model of sucrose-induced insulin resistance. Oxid Med Cell Longev. 2018;2018:2101562. https://doi.org/10.1155/2018/2101562.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Gnaiger E. Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology. Int J Biochem Cell Biol. 2009;41:1837–45. https://doi.org/10.1016/j.biocel.2009.03.013.

CAS  Article  PubMed  Google Scholar 

Ojuka E, Andrew B, Bezuidenhout N, George S, Maarman G, Madlala HP, Mendham A, Osiki PO. Measurement of beta-oxidation capacity of biological samples by respirometry: a review of principles and substrates. Am J Physiol Endocrinol Metab. 2016;310:E715–23. https://doi.org/10.1152/ajpendo.00475.2015.

Article  PubMed  Google Scholar 

Grossini E, Garhwal DP, Calamita G, Romito R, Rigamonti C, Minisini R, Smirne C, Surico D, Bellan M, Pirisi M. Exposure to plasma from non-alcoholic fatty liver disease patients affects hepatocyte viability, generates mitochondrial dysfunction, and modulates pathways involved in fat accumulation and inflammation. Front Med (Lausanne). 2021;8: 693997. https://doi.org/10.3389/fmed.2021.693997.

Article  Google Scholar